| Literature DB >> 28251152 |
Vikas Kataria1, Benjamin Berte1, Yves Vandekerckhove1, Rene Tavernier1, Mattias Duytschaever2.
Abstract
Background. Transseptal puncture (TSP) can be challenging. We compared safety and efficacy of a modified TSP technique ("mosquito" technique, MOSQ-TSP) to conventional TSP (CONV-TSP). Method. Patients undergoing AF ablation in whom first attempt of TSP did not result in left atrial (LA) pressure (failure to cross, FTC) were randomized to MOSQ-TSP (i.e., puncture of the fossa via a wafer-thin inner stylet) or CONV-TSP (i.e., additional punctures at different positions). Primary endpoint was LA access. Secondary endpoints were safety, time, fluoroscopic dose (dose-area product, DAP), and number of additional punctures from FTC to final LA access. Result. Of 384 patients, 68 had FTC (MOSQ-TSP, n = 34 versus CONV-TSP, n = 34). No complications were reported. In MOSQ-TSP, primary endpoint was 100% (versus 73.5%, p < 0.002), median time to LA access was 72 s [from 37 to 384 s] (versus 326 s [from 75 s to 1936 s], p < 0.002), mean DAP to LA access was 1778 ± 2315 mGy/cm2 (versus 9347 ± 10690 mGy/cm2, p < 0.002), and median number of additional punctures was 2 [1 to 3] (versus 0, p < 0.002). Conclusion. In AF patients in whom the first attempt of TSP fails, the "mosquito" technique allows effective, safe, and time sparing LA access. This approach might facilitate TSP in elastic, aneurysmatic, or fibrosed septa.Entities:
Mesh:
Year: 2017 PMID: 28251152 PMCID: PMC5303838 DOI: 10.1155/2017/2351925
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Study flowchart. After failure to cross at first needle puncture, patients were randomized to the mosquito arm or conventional arm. ITT, intention to treat.
Figure 2(a) The transseptal needle and its inner stylet. (b) Inner stylet inserted into the needle (to prevent scratching), now used to puncture the already stretched septum.
Figure 3Successful crossing of the septum via the “mosquito” technique. RAO 30° images and pressure recordings from the tip of the needle are presented at various stages of transseptal puncture (from (a) to (c)).
Baseline characteristics.
| MOSQ-TSP ( | CONV-TSP ( |
| |
|---|---|---|---|
| Age, years | 59.7 ± 9.1 | 59.2 ± 12.0 | 0.82 |
| Male, | 27 (79.4) | 25 (73.5) | 0.60 |
| Hypertension, | 7 (20.6) | 9 (26.5) | 0.42 |
| Structural heart disease, | 8 (23.5) | 5 (14.7) | 0.32 |
| Diabetes, | 0 (0) | 2 (5.9) | 0.16 |
| CHA2DS2VASc | 1.0 ± 1.2 | 1.1 ± 1.2 | 0.89 |
| Atrial diameter (PS-LAX), mm | 43.5 ± 6.2 | 41.7 ± 4.8 | 0.31 |
| Oral anticoagulants, | 22 (64.7) | 20 (59) | 0.87 |
| 1st procedure, | 17 (50) | 20 (58.8) | 0.50 |
| 2nd procedure, | 13 (38.2) | 9 (26.5) | 0.40 |
| 3rd procedure, | 5 (14.7) | 7 (20.6) | 0.64 |
| General anesthesia, | 14 (41.2) | 18 (52.9) | 0.16 |
| Weight, kg | 87.4 ± 18 | 84.9 ± 17 | 0.63 |
| TSP for AF ablation, | 28 (82.4) | 29 (85.3) | 0.66 |
PS-LAX, parasternal long-axis view; AF, atrial fibrillation.
Procedural outcomes of transseptal puncture.
| MOSQ-TSP ( | CONV-TSP ( |
| |
|---|---|---|---|
| Failure to cross at first site, | 34 (100) | 34 (100) | NS |
| Successful LA access, | 34 (100) | 25 (73.5) | <0.002 |
| Final LA access, | 34 (100) | 34 (100) | NS |
| Median time from FTC to final LA access, seconds (range) | 72 s | 326 s | <0.002 |
| DAP from FTC to final LA access, mGy/cm2 | 1778 ± 2315 | 9347 ± 10690 | <0.002 |
| Median | 0 | 2 (1 to 3) | <0.002 |
FTC, failure to cross the septum at the first attempt of puncture; LA, left atrium; DAP, dose-area product, NS, nonsignificant.